761
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Screening Circular RNA Related to Chemotherapeutic Resistance in Breast Cancer

, , , , , & show all
Pages 1175-1188 | Published online: 14 Aug 2017

References

  • Torre LA , BrayF , SiegelRL , FerlayJ , Lortet-TieulentJ , JemalA . Global cancer statistics, 2012 . CA Cancer J. Clin.65 ( 2 ), 87 – 108 ( 2015 ).
  • Suzuki H , ZuoY , WangJ , ZhangMQ , MalhotraA , MayedaA . Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing . Nucleic Acids Res.34 , e63 ( 2006 ).
  • Cocquerelle C , MascrezB , HétuinD , BailleulB . Mis-splicing yields circular RNA molecules . FASEB J.7 ( 1 ), 155 – 160 ( 1993 ).
  • Hentze MW , PreissT . Circular RNAs: splicing’s enigma variations . EMBO J.32 ( 7 ), 923 – 925 ( 2013 ).
  • Li J , YangJ , ZhouPet al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications . Am. J. Cancer Res.5 ( 2 ), 472 – 480 ( 2015 ).
  • Hansen TB , KjemsJ , DamgaardCK . Circular RNA and miR-7 in cancer . Cancer Res.73 ( 18 ), 5609 – 5612 ( 2013 ).
  • Bachmayr-Heyda A , ReinerAT , AuerKet al. Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues . Sci. Rep.5 , 8057 ( 2015 ).
  • Wang X , ZhangY , HuangLet al. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances . Int. J. Clin. Exp. Patho.8 ( 12 ), 16020 – 16025 ( 2015 ).
  • Li P , ChenS , ChenHet al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer . Clin. Chim. Acta444 , 132 – 136 ( 2015 ).
  • Su H , LinF , DengXet al. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells . J. Transl. Med.14 ( 1 ), 225 ( 2016 ).
  • Memczak S , JensM , ElefsiniotiAet al. Circular RNAs are a large class of animal RNAs with regulatory potency . Nature495 ( 7441 ), 333 – 338 ( 2013 ).
  • Hansen TB , JensenTI , ClausenBHet al. Natural RNA circles function as efficient microRNA sponges . Nature495 , 384 – 388 ( 2013 ).
  • Kefas B , GodlewskiJ , ComeauLet al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma . Cancer Res.68 ( 10 ), 3566 – 3572 ( 2008 ).
  • Jiang L , LiuX , ChenZet al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells . Biochem. J.432 ( 1 ), 199 – 205 ( 2010 ).
  • Xie H , RenX , XinSet al. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer . Oncotarget7 ( 18 ), 26680 – 26691 ( 2016 ).
  • Eisenhauer EA , TherasseP , BogaertsJet al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) . Eur. J. Cancer45 ( 2 ), 228 – 247 ( 2009 ).
  • Bustin SA , BenesV , GarsonJAet al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments . Clin. Chem.55 ( 4 ), 611 – 622 ( 2009 ).
  • Zhang X , FanY , LiuB , QiX , GuoZ , LiL . Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression . Breast Cancer24 ( 3 ), 433 – 441 ( 2017 ).
  • Huynh FC , JonesFE . MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance . PLoS ONE9 ( 12 ), e114419 ( 2014 ).
  • Lee KM , ChoiEJ , KimIA . microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling . Radiother. Oncol.101 ( 1 ), 171 – 176 ( 2011 ).
  • Hsiao YC , YehMH , ChenYJ , LiuJF , TangCH , HuangWC . Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK- dependent interleukin-6 . Oncotarget6 ( 35 ), 37965 – 37978 ( 2015 ).
  • Wang W , ZhouJ , ZhaoL , ChenS . Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells . Biomed. Pharmacother.88 , 985 – 990 ( 2017 ).
  • Miao Y , ZhengW , LiNet al. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway . Sci. Rep.7 , 41942 ( 2017 ).
  • Jeck WR , SorrentinoJA , WangKet al. Circular RNAs are abundant, conserved, and associated with ALU repeats . RNA19 ( 2 ), 141 – 157 ( 2013 ).
  • Raychaudhuri M , BrongerH , BuchnerT , KiechleM , WeichertW , AvrilS . MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer . Breast Cancer Res. Treat.162 ( 3 ), 511 – 521 ( 2017 ).
  • Chen PH , ChangCK , ShihCMet al. The miR-204–3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death . Neuropharmacology110 , 362 – 375 ( 2016 ).
  • Cui ZH , ShenSQ , ChenZB , HuC . Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204–3p and underlying mechanism . World J. Gastroenterol.20 ( 18 ), 5493 – 5504 ( 2014 ).
  • Wang C , FuSY , WangMDet al. Zinc finger protein X-linked (ZFX) promotes expansion of EpCAM+ cancer stem like cells in hepatocellular carcinoma . Mol. Oncol.11 ( 5 ), 455 – 469 ( 2017 ).
  • Ooi AT , GompertsBN . Molecular pathways: targeting cellular energy metabolism in cancer via inhibition of SLC2A1 and LDHA . Clin. Cancer Res.21 ( 11 ), 2440 – 2444 ( 2015 ).
  • O’Sullivan CC , BatesSE . Targeting prolactin receptor (PRLR) signaling in PRLR – positive breast and prostate cancer . Oncologist21 ( 5 ), 523 – 526 ( 2016 ).
  • Wang F , LuJ , PengXet al. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing . J. Exp. Clin. Cancer Res.35 , 17 ( 2016 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.